Cardiff Oncology, Inc. (CRDF)
NCM · Common · CUSIP 14147L108
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CRDF and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
14147L108 (prev. 897238101 )
Market Cap
Micro Cap
Previous Symbol
TROV (changed 5/8/2020)
Previous Name
TrovaGene, Inc.
Business: Cardiff Oncology, Inc. is a clinical-stage biotechnology company with the singular mission of developing new treatment options for cancer patients in indications with the greatest medical need.

Company Contact

CEO
Mark Erlander
CFO
James Levine
Headquarters
11055 Flintkote Avenue, Suite B, San Diego, CA 92121
Phone
858-952-7570
Investor Relations
James Levine · 858-952-7670 · jlevine@cardiffoncology.com
General Email
ir@cardiffoncology.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »